Research Advances in the Role of the Poly ADP Ribose Polymerase Family in Cancer

被引：4
|
作者：
Sha, Huanhuan [1 ]
Gan, Yujie [1 ]
Zou, Renrui [1 ]
Wu, Jianzhong [2 ]
Feng, Jifeng [1 ]
机构：
[1] Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Dept Chemotherapy,Affiliated Canc Hosp, Nanjing, Peoples R China
[2] Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Res Ctr Clin Oncol,Affiliated Canc Hosp, Nanjing, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词：
PARPs; ADP-ribosylation; cancer; mechanism; biological process; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; B-CELL LYMPHOMAS; BREAST-CANCER; POLY(ADP-RIBOSE) POLYMERASES; COLORECTAL-CANCER; MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR; OVARIAN-CANCER; PARP6; ACTS;
D O I：
10.3389/fonc.2021.790967
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Poly ADP ribose polymerases (PARPs) catalyze the modification of acceptor proteins, DNA, or RNA with ADP-ribose, which plays an important role in maintaining genomic stability and regulating signaling pathways. The rapid development of PARP1/2 inhibitors for the treatment of ovarian and breast cancers has advanced research on other PARP family members for the treatment of cancer. This paper reviews the role of PARP family members (except PARP1/2 and tankyrases) in cancer and the underlying regulatory mechanisms, which will establish a molecular basis for the clinical application of PARPs in the future.
引用
收藏
页数：11
相关论文
共 50 条
  • [31] Triple-negative Breast Cancer and Poly(ADP-ribose) Polymerase Inhibitors
    Park, Youngjin
    Moriyama, Ayako
    Kitahara, Tomoaki
    Yoshida, Yutaka
    Urita, Tasuku
    Kato, Ryoji
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2012, 12 (06) : 672 - 677
  • [32] Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?
    Papeo, Gianluca
    Forte, Barbara
    Orsini, Paolo
    Perrera, Claudia
    Posteri, Helena
    Scolaro, Alessandra
    Montagnoli, Alessia
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (10) : 1377 - 1400
  • [33] Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer
    Todorova, Tanya
    Bock, Florian J.
    Chang, Paul
    TRENDS IN MOLECULAR MEDICINE, 2015, 21 (06) : 373 - 384
  • [34] Current and future landscape of poly (ADP-ribose) polymerase inhibition resistance
    Hinchcliff, Emily
    Chelariu-Raicu, Anca
    Westin, Shannon N.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (01) : 19 - 25
  • [35] A Review on Poly (ADP-ribose) Polymerase (PARP) Inhibitors and Synthetic Methodologies
    Li, Ying
    Liu, Chenfu
    Rao, Guowu
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (08) : 1565 - 1584
  • [36] Poly(ADP-ribose)polymerase inhibition decreases angiogenesis
    Rajesh, Mohanraj
    Mukhopadhyay, Partha
    Godlewski, Grzegorz
    Batkai, Sandor
    Hasko, Gyorgy
    Liaudet, Lucas
    Pacher, Pal
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 350 (04) : 1056 - 1062
  • [37] Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy
    Miller, Rowan E.
    CANCER JOURNAL, 2021, 27 (06): : 506 - 510
  • [38] New inhibitors of poly(ADP-ribose) polymerase (PARP)
    Peukert, S
    Schwahn, U
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (11) : 1531 - 1551
  • [39] Research Advances in the Role of the Tropomyosin Family in Cancer
    Meng, Yucheng
    Huang, Ke
    Shi, Mingxuan
    Huo, Yifei
    Han, Liang
    Liu, Bin
    Li, Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
  • [40] PET of Poly (ADP-Ribose) Polymerase Activity in Cancer: Preclinical Assessment and First In-Human Studies
    Michel, Loren S.
    Dyroff, Samantha
    Brooks, Frank J.
    Spayd, Katherine J.
    Lim, Sora
    Engle, Jacquelyn T.
    Phillips, Sharon
    Tan, Benjamin
    Wang-Gillam, Andrea
    Bognar, Christopher
    Chu, Wenhua
    Zhou, Dong
    Mach, Robert H.
    Laforest, Richard
    Chen, Delphine L.
    RADIOLOGY, 2017, 282 (02) : 453 - 463
12345